Table 2.
Variable | Univariable | Multivariable | ||
---|---|---|---|---|
Hazard ratio (95% CI for Exp(B)) | p value | Hazard ratio (95% CI for Exp(B)) | p value | |
Local recurrence † | ||||
Distal resection margin < 0.9 (cm) | 7.7 (1.60–37.17) | 0.011* | 4.9 (1.00–24.42) | 0.050 |
Distance from anal verge ≤ 5 (cm) | 11.0 (1.37–87.89) | 0.024* | 7.1 (0.86–59.19) | 0.068 |
Family cancer history | 2.9 (0.78–10.88) | 0.111 | ||
Preoperative radiotherapy | 2.0 (0.24–15.93) | 0.533 | ||
T stage | 1.1 (0.28–4.50) | 0.878 | ||
Distant metastasis‡ | ||||
CEA ≥ 5 (ng/mL) | 6.1 (2.06–18.26) | 0.001* | 9.3 (2.79–30.76) | 0.0003* |
Lymph node yield < 14 | 3.5 (1.22–9.93) | 0.020* | 5.0 (1.57–15.63) | 0.006* |
Distal resection margin < 1.4 (cm) | 4.4 (1.23–15.91) | 0.023* | 4.0 (1.10–14.41) | 0.035* |
Tumor diameter ≥ 2.7 (cm) | 3.2 (0.89–11.50) | 0.074 | ||
Preoperative radiotherapy | 3.4 (1.16–9.86) | 0.025* | 3.8 (1.27–11.13) | 0.016* |
T stage | 1.4 (0.44–4.47) | 0.575 |
CEA carcinoembryonic antigen
*p value < 0.05
†Adjusted parameters (local recurrence): distal resection margin, distance from anal verge, family cancer history, preoperative radiotherapy, and T stage
‡Adjusted parameters (distant metastasis): CEA, distal resection margin, lymph node yield, tumor diameter, pre-operative radiotherapy, and T stage